Skip to main content

Table 4 Co-infections found in the patients included in the study, grouped by type of malaria

From: Migration-associated malaria from Africa in southern Spain

Co-infection N (%)

ALL

MM

SMM

p value

N = 329

239 (72.6%)

90 (27.4%)

Blastocystis hominis

40 (12.1%)

20 (8.4%)

20 (22.2%)

 ≤ 0.01

Entamoeba hystolitica/dispar

15 (4.5%)

6 (2.5%)

9 (10.0%)

 ≤ 0.05

Giardia lamblia

7 (2.1%)

5 (2.1%)

2 (2.2%)

1

Strongyloides stercoralis

31 (9.4%)

16 (6.7%)

15 (16.7%)

 ≤ 0.05

Hookworms

10 (3.0%)

3 (1.3%)

7 (7.8%)

 ≤ 0.01

Trichuris trichiura

2 (0.6%)

1 (0.4%)

1 (1.1%)

0.54

Ascaris lumbricoides

3 (0.9%)

1 (0.4%)

2 (2.2%)

0.25

Hymenolepsis nana

3 (0.9%)

0 (0.0%)

3 (3.3%)

 ≤ 0.05

Schistosomiasis*

22 (6.7%)

14 (5.9%)

8 (8.9%)

0.629

S. haematobium

6 (1.8%)

3 (1.3%)

3 (3.3%)

0.37

S. mansoni

6 (1.8%)

3 (1.3%)

3 (3.3%)

0.39

S. intercalatum

1 (0.3%)

0 (0.0%)

1 (1.1%)

0.32

Schistosoma spp.

5 (1.5%)

4 (1.7%)

1 (1.1%)

0.3

Filariae

14 (4.2%)

4 (1.7%)

10 (11.1%)

 ≤ 0.01

Mansonella perstans

13 (3.9%)

2 (0.8%)

9 (10.0%)

 ≤ 0.01

Loa loa

3 (0.9%)

0 (0.0%)

3 (3.3%)

 ≤ 0.05

Syphilis

23 (7.0%)

11 (4.6%)

12 (13.3%)

 ≤ 0.01

HBV

49 (14.9%)

24 (10.0%)

25 (27.8%)

 ≤ 0.01

HCV

2 (0.6%)

1 (0.4%)

1 (1.1%)

0.39

HIV

10 (3.0%)

9 (3.8%)

1 (1.1%)

0.29

  1. Quatitative variables: values are number (percentage), N (%).* Probable schistosomiasis was diagnosed in four patients based on clinical, analytical and imaging tests although no schistosome was found
  2. MM microscopic malaria, SMM submicroscopic malaria, HBV hepatitis B virus, HCV hepatitis C virus, HIV human immunodeficiency virus